GE HealthCare stock heads into the open after a September 9 slide
Published on 09/10/2026 at 07:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare stock closed at USD 66.78 on the Nasdaq on September 9, 2026, down 1.24% from the prior session according to Nasdaq data cited by MarketBeat. The decline came as the broader U.S. health care sector also lost ground in that session, with the Health Care Select Sector SPDR falling 2.6% on September 9, 2026 per data reported by Yahoo Finance.
September 9, 2026 in numbers
GE HealthCare Technologies Inc. (ISIN US36266G1076, Nasdaq: GEHC) ended the September 9, 2026 session at USD 66.78 on the Nasdaq, compared with its prior close of about USD 67.62, reflecting a 1.24% loss for the day per MarketBeat quote data. MarketBeat noted that shares of GEHC opened at USD 66.78 on Wednesday, indicating a trading range that stayed close to that level during the session. On the same date the S&P 500 slipped 0.5% to 7,636.36, showing that GE HealthCare underperformed the broader market, while the Health Care Select Sector SPDR dropped 2.6% as health care names broadly weakened according to a sector wrap from Yahoo Finance.
The stock’s recent performance comes against the backdrop of a Wells Fargo 21st Annual Healthcare Conference appearance on September 9, 2026, where management highlighted both order strength and margin headwinds. As Investing.com reported on September 9, 2026, GE HealthCare used the conference to emphasize 11% order growth, a book-to-bill ratio of 1.15 and backlog rising to USD 2.1 billion, but also pointed to tariff pressure, supply chain issues and a soft China market alongside a strategic review of its Patient Care Solutions unit. Sector pressure and the company’s ongoing margin challenges framed the weaker close on September 9, 2026 relative to the S&P 500 and the health care sector.
Today’s catalysts on September 10, 2026
Looking ahead to today’s session on September 10, 2026, investors can still digest the details from GE HealthCare’s Wells Fargo conference remarks, which management said support expectations for accelerating organic growth in the second half of 2024 and a medium-term operating margin objective of 17% to 20% as reported by Investing.com. In product news that may remain relevant into today’s trading, GE HealthCare recently announced that its StarGuide GX digital 4D CZT SPECT/CT technology is 510(k) pending with the U.S. Food and Drug Administration, a development highlighted on September 8, 2026 by Imaging Technology News. Broader market sentiment may also influence GE HealthCare today after U.S. indexes closed lower on September 9, 2026, with the S&P 500 down and health care shares under pressure, as summarized by Yahoo Finance.
